Cerebrovascular mitochondria as mediators of neuroinflammation in Alzheimer's Disease
脑血管线粒体作为阿尔茨海默病神经炎症的介质
基本信息
- 批准号:10723580
- 负责人:
- 金额:$ 11.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Abeta clearanceAccelerationAffectAgeAge MonthsAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloidAmyloid beta-42Amyloid beta-ProteinAmyloidosisAnimal ModelAnimalsAstrocytesBehavioralBiochemicalBioenergeticsBlood - brain barrier anatomyBlood VesselsBrainCRISPR/Cas technologyCell Culture TechniquesCell DeathCellsCerebral Amyloid AngiopathyCerebrovascular DisordersCerebrovascular systemCerebrumCommunicationDataDepositionDevelopmentDiseaseDisease ProgressionEndothelial CellsEndotheliumEventFailureFunctional disorderGatekeepingGenesGliosisHealthHemorrhageHomeostasisHumanImmunofluorescence ImmunologicImpaired cognitionIndividualInflammationInflammation MediatorsInflammatoryInflammatory ResponseLinkLoxP-flanked alleleMaintenanceMediatingMediatorMicrogliaMitochondriaMitochondrial DNAMitochondrial SwellingMolecularMovementMusNerve DegenerationNeurofibrillary TanglesNeurogliaNeuronsOral AdministrationPathogenesisPathologicPathologyPathway interactionsPatternPericytesPermeabilityProductionReactive Oxygen SpeciesResearchRoleRuptureSenile PlaquesSignal PathwaySuperoxidesTestingTherapeuticVariantVascular DiseasesVascular Endotheliumabeta accumulationabeta depositionblood-brain barrier permeabilizationbrain endothelial cellbrain healthcell injurycerebral microbleedscerebrovascularcognitive functioncyclophilin Deffective therapyexperimental studyextracellularhyperphosphorylated tauin vitro testingin vivoin vivo evaluationinduced pluripotent stem cellmitochondrial dysfunctionmitochondrial permeability transition poreneuroinflammationneurovascularneurovascular unitnon-dementednovelnovel therapeutic interventionpreventsensortau Proteinstoolvascular inflammation
项目摘要
ABSTRACT
In Alzheimer’s Disease (AD), and to a lesser extent in non-demented individuals, deposition of amyloid β (Aβ)
is found around cerebral vessels, a condition called Cerebral Amyloid Angiopathy (CAA). It is likely that the
development of CAA, and consequently neurovascular unit (NVU) dysfunction, in AD may result from failure of
Aβ clearance pathways. Importantly, all Aβ clearance pathways involve movement of Aβ towards the vasculature
for elimination. Cerebrovascular endothelial cells (EC), which line all brain vessels, are the gatekeepers of the
brain and are responsible for the maintenance of cerebral homeostasis through the blood-brain barrier (BBB).
The development of CAA severely impacts brain health since it results in EC death, BBB breakdown,
microhemorrhages, parenchymal Aβ accumulation, and is one of the earliest triggers for AD progression. EC
dysfunction also affects other cells of the NVU, such as astrocytes or microglia, through finely regulated
communication mechanism between these cells. Therefore, CAA-mediated EC dysfunction may also precipitate
neuroinflammation in AD. Our preliminary data suggests that EC mitochondria serve as important sensors of Aβ
damage. Previous studies have shown that mitochondria are responsible for the activation of inflammatory
pathways through the release of mitochondrial danger associated molecular patterns (mtDAMPs), including
mitochondrial reactive oxygen species (mtROS), due to formation of the pathological mitochondrial permeability
transition pore (mPTP). Both cerebrovascular dysfunction and inflammation are shown early in disease
pathogenesis, suggesting that early EC (and thus, BBB) dysfunction may drive and perpetuate AD pathology
also by triggering widespread neuroinflammation. Here, we will test the hypothesis that Aβ induces mitochondrial
dysfunction in cerebral ECs through deleterious alterations in mitochondria function (mtROS and mPTP opening)
and that these alterations further contribute to neurovascular dysfunction and inflammation in CAA and AD. This
proposal seeks to understand the role of alterations in cerebral EC mitochondrial health and bioenergetics,
specifically focusing on the modulation of mtROS and mPTP, on human EC inflammatory activation due to Aβ
(Aim 1; K99: Y1 and Y2). Moreover, we want to assess how Aβ-induced cerebral EC inflammatory mediators
contribute to glial mitochondrial dysfunction and activation, through the modulation of mtDAMPs, using a human
iPSC-derived glial cell cultures (Aim 2; K99: Y2 and R00: Y1). Finally, using an animal model of amyloidosis
presenting CAA and gliosis (TgSwDI), we will test the hypothesis that Aβ-induced endothelial mtROS and mPTP
mediate neuroinflammation and cognitive decline, by treating the animals with a mtROS scavenger or depleting
their ECs of CypD, the main mPTP regulator (Aim 3; R00: Y1-Y3). The proposed experiments will provide a
novel understanding of the role of vascular mitochondria as initiators of inflammation in AD and CAA, potentially
resulting in the development of new disease modifying therapeutic strategies.
抽象的
在阿尔茨海默病 (AD) 中,以及在较小程度上在非痴呆个体中,β 淀粉样蛋白 (Aβ) 的沉积
在脑血管周围发现这种疾病,称为脑淀粉样血管病 (CAA)。这很可能是
AD 中 CAA 的发展以及随后的神经血管单元 (NVU) 功能障碍可能是由于
Aβ 清除途径。重要的是,所有 Aβ 清除途径都涉及 Aβ 向脉管系统的移动
用于消除。脑血管内皮细胞 (EC) 排列在所有脑血管中,是大脑的看门人。
大脑并负责通过血脑屏障(BBB)维持大脑稳态。
CAA 的发展严重影响大脑健康,因为它会导致 EC 死亡、BBB 崩溃、
微出血、实质 Aβ 积聚,是 AD 进展的最早触发因素之一。欧共体
功能障碍还会通过精细调节影响 NVU 的其他细胞,例如星形胶质细胞或小胶质细胞
这些细胞之间的通讯机制。因此,CAA 介导的 EC 功能障碍也可能导致
AD 中的神经炎症。我们的初步数据表明 EC 线粒体是 Aβ 的重要传感器
损害。先前的研究表明线粒体负责炎症的激活
通过释放线粒体危险相关分子模式(mtDAMP)的途径,包括
线粒体活性氧 (mtROS),由于病理性线粒体通透性的形成
过渡孔(mPTP)。脑血管功能障碍和炎症均在疾病早期表现出来
发病机制,表明早期 EC(以及 BBB)功能障碍可能驱动并延续 AD 病理
还通过引发广泛的神经炎症。在这里,我们将检验 Aβ 诱导线粒体的假设
通过线粒体功能的有害改变(mtROS 和 mPTP 开放)导致大脑 EC 功能障碍
这些改变进一步导致 CAA 和 AD 的神经血管功能障碍和炎症。这
该提案旨在了解大脑 EC 线粒体健康和生物能量学改变的作用,
特别关注 mtROS 和 mPTP 的调节,以及 Aβ 引起的人类 EC 炎症激活
(目标 1;K99:Y1 和 Y2)。此外,我们想要评估 Aβ 诱导的脑 EC 炎症介质如何
通过使用人类的 mtDAMP 调节,导致胶质细胞线粒体功能障碍和激活
iPSC 衍生的神经胶质细胞培养物(目标 2;K99:Y2 和 R00:Y1)。最后,使用淀粉样变性动物模型
呈现 CAA 和神经胶质增生 (TgSwDI),我们将检验 Aβ 诱导的内皮 mtROS 和 mPTP 的假设
通过用 mtROS 清除剂或消耗剂治疗动物,介导神经炎症和认知能力下降
他们的 ECs CypD,主要的 mPTP 调节器(目标 3;R00:Y1-Y3)。所提出的实验将提供
对血管线粒体作为 AD 和 CAA 炎症引发剂的作用的新认识,可能
从而开发出新的疾病改变治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rebecca Maria Parodi-Rullan其他文献
Rebecca Maria Parodi-Rullan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
EXCESS: The role of excess topography and peak ground acceleration on earthquake-preconditioning of landslides
过量:过量地形和峰值地面加速度对滑坡地震预处理的作用
- 批准号:
NE/Y000080/1 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Research Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328975 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Continuing Grant
SHINE: Origin and Evolution of Compressible Fluctuations in the Solar Wind and Their Role in Solar Wind Heating and Acceleration
SHINE:太阳风可压缩脉动的起源和演化及其在太阳风加热和加速中的作用
- 批准号:
2400967 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Standard Grant
Market Entry Acceleration of the Murb Wind Turbine into Remote Telecoms Power
默布风力涡轮机加速进入远程电信电力市场
- 批准号:
10112700 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Collaborative R&D
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328973 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328972 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Continuing Grant
Collaborative Research: FuSe: R3AP: Retunable, Reconfigurable, Racetrack-Memory Acceleration Platform
合作研究:FuSe:R3AP:可重调、可重新配置、赛道内存加速平台
- 批准号:
2328974 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Continuing Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332916 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Standard Grant
Collaborative Research: A new understanding of droplet breakup: hydrodynamic instability under complex acceleration
合作研究:对液滴破碎的新认识:复杂加速下的流体动力学不稳定性
- 批准号:
2332917 - 财政年份:2024
- 资助金额:
$ 11.17万 - 项目类别:
Standard Grant
Study of the Particle Acceleration and Transport in PWN through X-ray Spectro-polarimetry and GeV Gamma-ray Observtions
通过 X 射线光谱偏振法和 GeV 伽马射线观测研究 PWN 中的粒子加速和输运
- 批准号:
23H01186 - 财政年份:2023
- 资助金额:
$ 11.17万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




